• Home
  • Pharmaceuticals and Healthcare
Dynamics in Post-pandemic Global Herpes Simplex Virus (HSV) Vaccines Industry: Supply and Demand, Markets and Prices 2021-2027

Dynamics in Post-pandemic Global Herpes Simplex Virus (HSV) Vaccines Industry: Supply and Demand, Markets and Prices 2021-2027

Report Code: KNJ668128 | No. of Pages: 139 | Category: Pharmaceuticals and Healthcare
Publisher: GRD Survey | Date of Publish: Apr-2021 
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Herpes Simplex Virus (HSV) Vaccines market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Herpes Simplex Virus (HSV) Vaccines market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
GEN-003

VCL-HB01

HSV529

Others

Segmented by End User/Segment
HSV-1 (Oral Herpes)

HSV-2 (Genital Herpes)

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Vical

Sanofi

GlaxoSmithKline

Genocea Biosciences



Table of Contents

1 Product Introduction and Overview
    1.1 Product Definition
    1.2 Product Specification
    1.3 Global Market Overview
        1.3.1 Global Herpes Simplex Virus (HSV) Vaccines Market Status and Forecast (2016-2027)
        1.3.2 Global Herpes Simplex Virus (HSV) Vaccines Sales Value CAGR by Region
    1.4 Market Drivers, Inhibitors
        1.4.1 Market Drivers
        1.4.2 Market Inhibitors
        1.4.3 COVID-19 Impact Analysis
2 Global Herpes Simplex Virus (HSV) Vaccines Supply by Company
    2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Volume by Company
    2.2 Global Herpes Simplex Virus (HSV) Vaccines Sales Value by Company
    2.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Company
    2.4 Herpes Simplex Virus (HSV) Vaccines Production Location and Sales Area of Main Manufacturers
    2.5 Trend of Concentration Rate
3 Global and Regional Herpes Simplex Virus (HSV) Vaccines Market Status by Category
    3.1 Herpes Simplex Virus (HSV) Vaccines Category Introduction
        3.1.1 GEN-003

        3.1.2 VCL-HB01

        3.1.3 HSV529

        3.1.4 Others
    3.2 Global Herpes Simplex Virus (HSV) Vaccines Market by Category
        3.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Volume by Category (2016-2021)
        3.2.2 Global Herpes Simplex Virus (HSV) Vaccines Sales Value by Category (2016-2021)
        3.2.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Category (2016-2021)
    3.3 North America: by Category
    3.4 Europe: by Category
    3.5 Asia Pacific: by Category
    3.6 Central & South America: by Category
    3.7 Middle East & Africa: by Category
4 Global and Regional Herpes Simplex Virus (HSV) Vaccines Market Status by End User/Segment
    4.1 Herpes Simplex Virus (HSV) Vaccines Segment by End User/Segment
        4.1.1 HSV-1 (Oral Herpes)

        4.1.2 HSV-2 (Genital Herpes)
    4.2 Global Herpes Simplex Virus (HSV) Vaccines Market by End User/Segment
        4.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Volume by End User/Segment (2016-2021)
        4.2.2 Global Herpes Simplex Virus (HSV) Vaccines Sales Value by End User/Segment (2016-2021)
        4.2.3 Global Herpes Simplex Virus (HSV) Vaccines Price by End User/Segment (2016-2021)
    4.3 North America: by End User/Segment
    4.4 Europe: by End User/Segment
    4.5 Asia Pacific: by End User/Segment
    4.6 Central & South America: by End User/Segment
    4.7 Middle East & Africa: by End User/Segment
5 Global Herpes Simplex Virus (HSV) Vaccines Market Status by Region
    5.1 Global Herpes Simplex Virus (HSV) Vaccines Market by Region
        5.1.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Volume by Region
        5.1.2 Global Herpes Simplex Virus (HSV) Vaccines Sales Value by Region
    5.2 North America Herpes Simplex Virus (HSV) Vaccines Market Status
    5.3 Europe Herpes Simplex Virus (HSV) Vaccines Market Status
    5.4 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Status
    5.5 Central & South America Herpes Simplex Virus (HSV) Vaccines Market Status
    5.6 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Market Status
6 North America Herpes Simplex Virus (HSV) Vaccines Market Status
    6.1 North America Herpes Simplex Virus (HSV) Vaccines Market by Country
        6.1.1 North America Herpes Simplex Virus (HSV) Vaccines Sales Volume by Country (2016-2021)
        6.1.2 North America Herpes Simplex Virus (HSV) Vaccines Sales Value by Country (2016-2021)
    6.2 United States
    6.3 Canada
    6.4 Mexico
7 Europe Herpes Simplex Virus (HSV) Vaccines Market Status
    7.1 Europe Herpes Simplex Virus (HSV) Vaccines Market by Country
        7.1.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales Volume by Country (2016-2021)
        7.1.2 Europe Herpes Simplex Virus (HSV) Vaccines Sales Value by Country (2016-2021)
    7.2 Germany
    7.3 France
    7.4 UK
    7.5 Italy
    7.6 Russia
    7.7 Spain
8 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Status
   8.1 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market by Country
        8.1.1 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales Volume by Country (2016-2021)
        8.1.2 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales Value by Country (2016-2021)
    8.2 China
    8.3 Japan
    8.4 Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australasia
9 Central & South America Herpes Simplex Virus (HSV) Vaccines Market Status
    9.1 Central & South America Herpes Simplex Virus (HSV) Vaccines Market by Country
        9.1.1 Central & South America Herpes Simplex Virus (HSV) Vaccines Sales Volume by Country (2016-2021)
        9.1.2 Central & South America Herpes Simplex Virus (HSV) Vaccines Sales Value by Country (2016-2021)
    9.2 Brazil
    9.3 Argentina
    9.4 Colombia
10 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Market Status
    10.1 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Market by Country
        10.1.1 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Volume by Country (2016-2021)
        10.1.2 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Value by Country (2016-2021)
    10.2 Iran
    10.3 Israel
    10.4 Turkey
    10.5 South Africa
    10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
    11.1 Supply Chain Analysis
    11.2 Production Process Chart Analysis
    11.3 Raw Materials and Key Suppliers Analysis
        11.3.1 Raw Materials Introduction
        11.3.2 Raw Materials Key Suppliers List
    11.4 Herpes Simplex Virus (HSV) Vaccines Manufacturing Cost Analysis
    11.5 Herpes Simplex Virus (HSV) Vaccines Sales Channel and Distributors Analysis
        11.5.1 Herpes Simplex Virus (HSV) Vaccines Sales Channel
        11.5.2 Herpes Simplex Virus (HSV) Vaccines Distributors
    11.6 Herpes Simplex Virus (HSV) Vaccines Downstream Major Buyers
12 Global Herpes Simplex Virus (HSV) Vaccines Market Forecast by Category and by End User/Segment
    12.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Volume and Sales Value Forecast (2022-2027)
    12.2 Global Herpes Simplex Virus (HSV) Vaccines Forecast by Category
        12.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Volume Forecast by Category
        12.2.2 Global Herpes Simplex Virus (HSV) Vaccines Sales Value Forecast by Category
        12.2.3 Global Herpes Simplex Virus (HSV) Vaccines Price Forecast by Category
    12.3 Global Herpes Simplex Virus (HSV) Vaccines Forecast by End User/Segment
        12.3.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Volume Forecast by End User/Segment
        12.3.2 Global Herpes Simplex Virus (HSV) Vaccines Sales Value Forecast by End User/Segment
        12.3.3 Global Herpes Simplex Virus (HSV) Vaccines Price Forecast by End User/Segment
13 Global Herpes Simplex Virus (HSV) Vaccines Market Forecast by Region/Country
    13.1 Global Herpes Simplex Virus (HSV) Vaccines Market Forecast by Region (2022-2027)
        13.1.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Volume Forecast by Region (2022-2027)
        13.1.2 Global Herpes Simplex Virus (HSV) Vaccines Sales Value Forecast by Region (2022-2027)
    13.2 North America Market Forecast
    13.3 Europe Market Forecast
    13.4 Asia Pacific Market Forecast
    13.5 Central & South America Market Forecast
    13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
    14.1 Vical

        14.1.1 Company Information
        14.1.2 Herpes Simplex Virus (HSV) Vaccines Product Introduction
        14.1.3 Vical
 Herpes Simplex Virus (HSV) Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.1.4 SWOT Analysis
    14.2 Sanofi

        14.2.1 Company Information
        14.2.2 Herpes Simplex Virus (HSV) Vaccines Product Introduction
        14.2.3 Sanofi
 Herpes Simplex Virus (HSV) Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.2.4 SWOT Analysis
    14.3 GlaxoSmithKline

        14.3.1 Company Information
        14.3.2 Herpes Simplex Virus (HSV) Vaccines Product Introduction
        14.3.3 GlaxoSmithKline
 Herpes Simplex Virus (HSV) Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.3.4 SWOT Analysis
    14.4 Genocea Biosciences

        14.4.1 Company Information
        14.4.2 Herpes Simplex Virus (HSV) Vaccines Product Introduction
        14.4.3 Genocea Biosciences
 Herpes Simplex Virus (HSV) Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.4.4 SWOT Analysis
    ...
15 Conclusion
16 Methodology

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com